Clinical Trial Update: Sickle Cell Disease, Hemechip

View source ↗

Summary

A completed clinical trial evaluating Hemechip for sickle cell disease conducted at University Hospitals Cleveland Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Hemechip

Snippet

Sponsor: University Hospitals Cleveland Medical Center | Conditions: Sickle Cell Disease | Status: COMPLETED